Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Oragenics Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +2 vs. Q3 2023
- Shares held
- 62.1K
- +698 (+1.1%) vs. Q3 2023
- Total value
- $349.5K
- +$167.4K (+91.9%) vs. Q3 2023
- New holders
- 2
- 2 more added
- Sold out
- 0
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $192.4K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $3.06M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.96M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 22,148 | $124.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,798 | $111.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,428 | $87.0K | 0.00% | +1,900+14.0% | Added |
| FMR LLC | 2,597 | $14.6K | 0.00% | −5−0.2% | Reduced |
| Tower Research Capital LLC (TRC) | 1,887 | $10.6K | 0.00% | −1,108−37.0% | Reduced |
| Bank of America Corp | 113 | $636 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 33 | $186 | 0.00% | −95−74.2% | Reduced |
| Advisor Group Holdings, Inc. | 23 | $128 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 21 | $119 | 0.00% | +1+5.0% | Added |
| Wolff Wiese Magana LLC | 17 | $96 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4 | $23 | 0.00% | +4 | New |
| Chesapeake Asset Management LLC | 3 | $16 | 0.00% | 00.0% | Unchanged |
| Team Financial Group, LLC | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 1 | $6 | 0.00% | +1 | New |
| Royal Bank of Canada | 5 | $0 | 0.00% | 00.0% | Unchanged |